These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 18519748

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tumor progression associated with erythropoiesis-stimulating agents.
    Newland AM, Black CD.
    Ann Pharmacother; 2008 Dec; 42(12):1865-70. PubMed ID: 19017828
    [Abstract] [Full Text] [Related]

  • 5. Erythropoiesis-stimulating agents: favorable safety profile when used as indicated.
    Nowrousian MR, Dunst J, Vaupel P.
    Strahlenther Onkol; 2008 Mar; 184(3):121-36. PubMed ID: 18330508
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Venous thromboembolic events and erythropoiesis-stimulating agents: an update.
    Dicato M.
    Oncologist; 2008 Mar; 13 Suppl 3():11-5. PubMed ID: 18458119
    [Abstract] [Full Text] [Related]

  • 8. Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses.
    Vansteenkiste J, Glaspy J, Henry D, Ludwig H, Pirker R, Tomita D, Collins H, Crawford J.
    Lung Cancer; 2012 Jun; 76(3):478-85. PubMed ID: 22277104
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anemia management in oncology and hematology.
    Spivak JL, Gascón P, Ludwig H.
    Oncologist; 2009 Jun; 14 Suppl 1():43-56. PubMed ID: 19762516
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Erythropoiesis-stimulating agents in cancer patients: reflections on safety.
    Wauters I, Vansteenkiste J.
    Expert Rev Clin Pharmacol; 2011 Jul; 4(4):467-76. PubMed ID: 22114856
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The role of the pharmacist in optimizing the use of erythropoietin stimulating agents.
    Gebara SN, Moubayed H.
    J Oncol Pharm Pract; 2010 Mar; 16(1):33-7. PubMed ID: 19401308
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000-2007.
    Wu Y, Aravind S, Ranganathan G, Martin A, Nalysnyk L.
    Clin Ther; 2009 Mar; 31 Pt 2():2416-32. PubMed ID: 20110050
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.